Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer

Cancer Letters

Volumn 300, Issue 1, 2011, Pages 79-86

  Daskalos, Alexandros ^a   Logotheti, Stella ^b   Markopoulou, Soultana ^a   Xinarianos, George ^a   Gosney, John R ^a   Kastania, Anastasia N ^c   Zoumpourlis, Vassilis ^b   Field, John K ^a   Liloglou, Triantafillos ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b INSTITUTE OF BIOLOGY   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Np73; DNA methylation; Lung cancer; P73; TAp73

Indexed keywords

DNA; MESSENGER RNA; PROTEIN P73;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 78549270385     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.09.009     Document Type: Article

References (28)

1. Pozniak C.D., Radinovic S., Yang A., McKeon F., Kaplan D.R., Miller F.D. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 2000, 289:304-306.
2. Stiewe T., Theseling C.C., Putzer B.M. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J. Biol. Chem. 2002, 277:14177-14185.
3. Grob T.J., Novak U., Maisse C., Barcaroli D., Luthi A.U., Pirnia F., Hugli B., Graber H.U., De Laurenzi V., Fey M.F., Melino G., Tobler A. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 2001, 8:1213-1223.
4. Stiewe T., Zimmermann S., Frilling A., Esche H., Putzer B.M. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res. 2002, 62:3598-3602.
5. Moll U.M., Slade N. p63 and p73: roles in development and tumor formation. Mol. Cancer Res. 2004, 2:371-386.
6. Stiewe T., Tuve S., Peter M., Tannapfel A., Elmaagacli A.H., Putzer B.M. Quantitative TP73 transcript analysis in hepatocellular carcinomas. Clin. Cancer Res. 2004, 10:626-633.
7. Esteller M., Herman J.G. Cancer as an epigenetic disease-DNA methylation and chromatin alterations in human tumours. J. Pathol. 2002, 196:1-7.
8. Wu H., Chen Y., Liang J., Shi B., Wu G., Zhang Y., Wang D., Li R., Yi X., Zhang H., Sun L., Shang Y. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 2005, 438:981-987.
9. Jun H.J., Woolfenden S., Coven S., Lane K., Bronson R., Housman D., Charest A. Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas. Cancer Res. 2009, 69:2180-2184.
10. Cui L., Xu L.Y., Shen Z.Y., Tao Q., Gao S.Y., Lv Z., Du Z.P., Fang W.K., Li E.M. NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma. Clin. Cancer Res. 2008, 14:7674-7681.
11. De Smet C., Loriot A. DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey. Epigenetics 2010, 5:206-213.
12. Costello J.F., Frühwald M.C., Smiraglia D.J., Rush L.J., Robertson G.P., Gao X., Wright F.A., Feramisco J.D., Peltomäki P., Lang J.C., Schuller D.E., Yu L., Bloomfield C.D., Caligiuri M.A., Yates A., Nishikawa R., Su Huang H., Petrelli N.J., Zhang X., O'Dorisio M.S., Held W.A., Cavenee W.K., Plass C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 2000, 24:132-138.
13. Corn P.G., Kuerbitz S.J., van Noesel M.M., Esteller M., Compitello N., Baylin S.B., Herman J.G. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res. 1999, 59:3352-3356.
14. Pluta A., Nyman U., Joseph B., Robak T., Zhivotovsky B., Smolewski P. The role of p73 in hematological malignancies. Leukemia 2006, 20:757-766.
15. Martinez-Delgado B., Melendez B., Cuadros M., Garcia M.J., Nomdedeu J., Rivas C. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas. Int. J. Cancer 2002, 102:15-19.
16. Siu L.L., Chan J.K., Wong K.F., Kwong Y.L. Specific patterns of gene methylation in natural killer lymphomas: p73 is consistently involved. Am. J. Pathol. 2002, 160:59-66.
17. Banelli B., Casciano I., Romani M. Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene 2000, 19:4553-4556.
18. Casciano I., Banelli B., Croce M., Allemanni G., Ferrini S., Tonini G.P., Ponzoni M., Romani M. Role of methylation in the control of ΔNp73 expression in neuroblastoma. Cell Death Differ. 2002, 9:343-345.
19. Di Vinci A., Sessa F., Casciano I., Banelli B., Franzi F., Brigati C., Allemanni G., Russo P., Dominioni L., Romani M. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer. Int. J. Oncol. 2009, 34:449-456.
20. Chalitchagorn K., Shuangshoti S., Hourpai N., Kongruttanachok N., Tangkijvanich P., Thong-ngam D., Voravud N., Sriuranpong V., Mutirangura A. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004, 23:8841-8846.
21. Weisenberger D.J., Campan M., Long T.I., Kim M., Woods C., Fiala E., Ehrlich M., Laird P.W. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005, 33:6823-6836.
22. Daskalos A., Nikolaidis G., Xinarianos G., Savvari P., Cassidy A., Zakopoulou R., Kotsinas A., Gorgoulis V., Field J.K., Liloglou T. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int. J. Cancer 2009, 124:81-87.
23. Logotheti S., Michalopoulos I., Sideridou M., Daskalos A., Kossida S., Spandidos D.A., Field J.K., Vojtesek B., Liloglou T., Gorgoulis V., Zoumpourlis V. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer. FEBS J. 2010, 277:3014-3027.
24. Shaw R.J., Akufo-Tetteh E.K., Risk J.M., Field J.K., Liloglou T. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing. Nucleic Acids Res. 2006, 34:e78.
25. Uramoto H., Sugio K., Oyama T., Nakata S., Ono K., Morita M., Funa K., Yasumoto K. Expression of deltaNp73 predicts poor prognosis in lung cancer. Clin. Cancer Res. 2004, 10:6905-6911.
26. Uramoto H., Sugio K., Oyama T., Nakata S., Ono K., Nozoe T., Yasumoto K. Expression of the p53 family in lung cancer. Anticancer Res. 2006, 26:1785-1790.
27. Saito K., Kawakami K., Matsumoto I., Oda M., Watanabe G., Minamoto T. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clin. Cancer Res. 2010, 16:2418-2426.
28. Wilhelm M.T., Rufini A., Wetzel M.K., Tsuchihara K., Inoue S., Tomasini R., Itie-Youten A., Wakeham A., Arsenian-Henriksson M., Melino G., Kaplan D.R., Miller F.D., Mak T.W. Isoform-specific p73 knockout mice reveal a novel role for {Delta}Np73 in the DNA damage response pathway. Genes Dev. 2010, 24:549-560.